http://orcid.org/0000-0003-2329-2280
About the Authors
- Constantinos Kurt Wibmer
-
Affiliations Centre for HIV and STIs, National Institute for Communicable Diseases (NICD), of the National Health Laboratory Service (NHLS), Johannesburg, South Africa, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- Jason Gorman
-
Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
- Gabriel Ozorowski
-
Affiliation Department of Integrative Structural and Computational Biology, CHAVI-ID, IAVI Neutralizing Antibody Center and Collaboration for AIDS Vaccine Discovery (CAVD), The Scripps Research Institute, La Jolla, California, United States of America
- Jinal N. Bhiman
-
Affiliations Centre for HIV and STIs, National Institute for Communicable Diseases (NICD), of the National Health Laboratory Service (NHLS), Johannesburg, South Africa, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- Daniel J. Sheward
-
Affiliation Institute of Infectious Disease and Molecular Medicine (IDM) and Division of Medical Virology, University of Cape Town and NHLS, Cape Town, South Africa
- Debra H. Elliott
-
Affiliation Department of Pediatrics, Tulane University Medical Center, New Orleans, Louisiana, United States of America
- Julie Rouelle
-
Affiliation Department of Pediatrics, Tulane University Medical Center, New Orleans, Louisiana, United States of America
- Ashley Smira
-
Affiliation Department of Pediatrics, Tulane University Medical Center, New Orleans, Louisiana, United States of America
- M. Gordon Joyce
-
Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
- Nonkululeko Ndabambi
-
Affiliation Institute of Infectious Disease and Molecular Medicine (IDM) and Division of Medical Virology, University of Cape Town and NHLS, Cape Town, South Africa
- Aliaksandr Druz
-
Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
- Mangai Asokan
-
Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
- Dennis R. Burton
-
Affiliations Department of Immunology and Microbial Science, CHAVI-ID and IAVI Neutralizing Antibody Centre, The Scripps Research Institute, La Jolla, California, United States of America, Ragon Institute of Massachusetts General Hospital, MIT and Harvard, Cambridge, Massachusetts, United States of America
- Mark Connors
-
Affiliation Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
- Salim S. Abdool Karim
-
Affiliations Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa, Department of Epidemiology, Columbia University, New York, New York, United States of America
- John R. Mascola
-
Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
- James E. Robinson
-
Affiliation Department of Pediatrics, Tulane University Medical Center, New Orleans, Louisiana, United States of America
- Andrew B. Ward
-
Affiliation Department of Integrative Structural and Computational Biology, CHAVI-ID, IAVI Neutralizing Antibody Center and Collaboration for AIDS Vaccine Discovery (CAVD), The Scripps Research Institute, La Jolla, California, United States of America
- Carolyn Williamson
-
Affiliations Institute of Infectious Disease and Molecular Medicine (IDM) and Division of Medical Virology, University of Cape Town and NHLS, Cape Town, South Africa, Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa
- Peter D. Kwong
-
Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
- Lynn Morris
-
* E-mail: pennym@nicd.ac.za (PLM); lynnm@nicd.ac.za (LM)
Affiliations Centre for HIV and STIs, National Institute for Communicable Diseases (NICD), of the National Health Laboratory Service (NHLS), Johannesburg, South Africa, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa
- Penny L. Moore
-
* E-mail: pennym@nicd.ac.za (PLM); lynnm@nicd.ac.za (LM)
Affiliations Centre for HIV and STIs, National Institute for Communicable Diseases (NICD), of the National Health Laboratory Service (NHLS), Johannesburg, South Africa, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceptualization: CKW CW PDK LM PLM. Investigation: CKW JG GO JNB DJS DHE JR AS MGJ NN AD MA DRB JRM JER ABW. Resources: DRB MC SSAK. Writing – original draft: CKW PDK LM PLM. Writing – review & editing: CKW JG DRB MC JER ABW CW.